Navigating regulatory change, overseeing the deployment of AI in healthcare organizations, and preventing and detecting healthcare fraud were among the topics discussed by industry participants, regulators and service providers gathered in Washington, DC, last week at the 26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress (PCC).
Speakers pointed